Flow cytometric analysis of circulating endothelial cells and endothelial progenitors for clinical purposes in oncology: A critical evaluation (Review)

Danova,Marco; Comolli,Giuditta; Manzoni,Mariangela; Torchio,Martina; Mazzini,Giuliano

doi:10.3892/mco.2016.823

Flow cytometric analysis of circulating endothelial cells and endothelial progenitors for clinical purposes in oncology: A critical evaluation (Review)

Authors:
- Marco Danova
- Giuditta Comolli
- Mariangela Manzoni
- Martina Torchio
- Giuliano Mazzini
View Affiliations

Affiliations: Internal Medicine and Medical Oncology, Vigevano Hospital, ASST Pavia, I‑27029 Vigevano, Italy, Microbiology and Virology, Biotechnology Laboratories, IRCCS San Matteo Foundation, I‑27100 Pavia, Italy, Medical Oncology, Crema Hospital, Crema I‑26013, Italy, Molecular Genetics Institute, National Research Council and Biology and Biotechnology Department ‘L. Spallanzani’, University of Pavia, I‑27100 Pavia, Italy
Published online on: March 18, 2016 https://doi.org/10.3892/mco.2016.823
Pages: 909-917

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Malignant tumors are characterized by uncontrolled cell growth and metastatic spread, with a pivotal importance of the phenomenon of angiogenesis. For this reason, research has focused on the development of agents targeting the vascular component of the tumor microenvironment and regulating the angiogenic switch. As a result, the therapeutic inhibition of angiogenesis has become an important component of anticancer treatment, however, its utility is partly limited by the lack of an established methodology to assess its efficacy in vivo. Circulating endothelial cells (CECs), which are rare in healthy subjects and significantly increased in different tumor types, represent a promising tool for monitoring the tumor clinical outcome and the treatment response. A cell population circulating into the blood also able to form endothelial colonies in vitro and to promote vasculogenesis is represented by endothelial progenitor cells (EPCs). The number of both of these cell types is extremely low and they cannot be identified using a single marker, therefore, in absence of a definite consensus on their phenotype, require discrimination using combinations of antigens. Multiparameter flow cytometry (FCM) is ideal for rapid processing of high numbers of cells per second and is commonly utilized to quantify CECs and EPCs, however, remains technically challenging since there is as yet no standardized protocol for the identification and enumeration of these rare events. Methodology in studies on CECs and/or EPCs as clinical biomarkers in oncology is heterogeneous and data have been obtained from different studies leading to conflicting conclusions. The present review presented a critical review of the issues that limit the comparability of results of the most significant studies employing FCM for CEC and/or EPC detection in patients with cancer.

View Figures

View References

1	Goon PK, Lip GY, Boos CJ, Stonelake PS and Blann D: Circulating endothelial cells, endothelial progenitor cells and endothelial microparticles in cancer. Neoplasia. 8:79–88. 2006. View Article : Google Scholar : PubMed/NCBI
2	Kraan J, Sleijfer S, Foekens JA and Gratama JW: Clinical value of circulating endothelial cell detection in oncology. Drug Discov Today. 17:710–717. 2012. View Article : Google Scholar : PubMed/NCBI
3	Koutrompi M, Dimopoulos S, Psarra K, Kypirianou T and Nanas S: Circulating endothelial and progenitor cells: Evidence from acute and long-term exercise effects. World J Cardiol. 4:312–326. 2012. View Article : Google Scholar : PubMed/NCBI
4	Costiniuk CT, Hibert BM, Simard T, Ghazawi FM, Angel JB and O'Brien ER: Circulating endothelial progenitor cells in HIV infection: A systematic review. Trends Cardiovasc Med. 23:192–200. 2013. View Article : Google Scholar : PubMed/NCBI
5	King TF and McDermott JH: Endothelial progenitor cells and cardiovascular disease. J Stem Cells. 9:93–106. 2014.PubMed/NCBI
6	Strijbos MH, Gratama JW, Kraan J, Lamers CH, den Bakker MA and Sleijfer S: Circulating endothelial cells in oncology: Pitfalls and promises. Br J Cancer. 98:1731–1735. 2008. View Article : Google Scholar : PubMed/NCBI
7	Timmermans F, Plum J, Yöder MC, Ingram DA, Vandekerckhove B and Case J: Endothelial progenitor cells: Identity defined? J Cell Mol Med. 13:87–102. 2009. View Article : Google Scholar : PubMed/NCBI
8	Hedley BD and Keeney M: Technical issues: Flow cytometry and rare event analysis. Int J Lab Hematol. 35:344–350. 2013. View Article : Google Scholar : PubMed/NCBI
9	Masouleh BK, Baraniskin A, Schmiegel W and Schroers R: Quantification of circulating endothelial progenitor cells in human peripheral blood: Establishing a reliable flow cytometric protocol. J Immunol Methods. 357:38–42. 2010. View Article : Google Scholar : PubMed/NCBI
10	Mund JA, Estes ML, Yoder MC, Ingram DA Jr and Case J: Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells. Arterioscler Thromb Vasc Biol. 32:1045–1053. 2012. View Article : Google Scholar : PubMed/NCBI
11	Nielsen MH, Beck-Nielsen H, Andersen MN and Handberg A: A flow cytometric method for characterization of circulating cell-derived microparticles in plasma. J Extracell Vescicles. 3:10.3402/jev.v3.2079532014.
12	Kraan J, Strijbos MH, Sieuwerts AM, Foekens JA, den Bakker MA, Verhoef C, Sleijfer S and Gratama JW: A new approach for rapid and reliable enumeration of circulating endothelial cells in patients. J Thromb Haemost. 10:931–939. 2012. View Article : Google Scholar : PubMed/NCBI
13	Bertolini F, Shaked Y, Mancuso P and Kerbel RS: The multifaced circulating endothelial cell in cancer: Towards marker and target identification. Nat Rev Cancer. 6:835–845. 2006. View Article : Google Scholar : PubMed/NCBI
14	Sutherland DR, Anderson L, Keeney M, Nayar R and Chin-Yee I: The ISHAGE guidelines for CD34+cell determination by flow cytometry. International society of haematotherapy and graft Engineering. J Haematother. 5:213–226. 1996. View Article : Google Scholar
15	Mancuso P and Bertolini F: Circulating endothelial cells as biomarkers in clinical oncology. Microvasc Res. 79:224–228. 2010. View Article : Google Scholar : PubMed/NCBI
16	Goodale D, Phay C, Brown W, Gray-Statchuk L, Furlong P, Lock M, Chin-Yee I, Keeney M and Allan AL: Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer. Cytometry B Clin Cytom. 76:107–117. 2009. View Article : Google Scholar : PubMed/NCBI
17	Goon PK, Lip GY, Stonelake S and Blann AD: Circulating endothelial cells and circulating progenitor cells in breast cancer: Relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors and the Nottingham prognostic index. Neoplasia. 11:771–779. 2009. View Article : Google Scholar : PubMed/NCBI
18	Kuo YH, Lin CH, Shau WY, Chen TJ, Yang SH, Huang SM, Hsu C, Lu YS and Cheng AL: Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy. BMC Cancer. 12:6202012. View Article : Google Scholar : PubMed/NCBI
19	Vroling L, Lind JS, de Haas RR, Verheul HM, van Hinsbergh VW, Broxterman HJ and Smith EF: CD133+ circulating hematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients. Br J Cancer. 102:268–275. 2010. View Article : Google Scholar : PubMed/NCBI
20	Yuan DM, Zhang Q, Lu YL, Ma XQ, Zhan Y, Liu HB and Song Y: Predictive and prognostic significance of circulating endothelial cells in advanced non-small cell lung cancer patients. Tumor Biol. 36:9031–9037. 2015. View Article : Google Scholar
21	Ronzoni M, Manzoni M, Mariucci S, Loupakis F, Brugnatelli S, Bencardino K, Rovati B, Tinelli C, Falcone A, Villa E and Danova M: Circulating endothelial cells and endothelial progenitor as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients. Ann Oncol. 21:2382–2389. 2010. View Article : Google Scholar : PubMed/NCBI
22	Manzoni M, Mariucci S, Delfanti S, Rovati B, Ronzoni M, Loupakis F, Brugnatelli S, Tinelli C, Villa E, Falcone A and Danova M: Circulating endothelial cells and apoptotic fraction are mutually independent predictive biomarkers in bevacizumab-based treatment for advanced colorectal cancer. J Cancer Res Clin oncol. 138:1187–1196. 2012. View Article : Google Scholar : PubMed/NCBI
23	Ramcharan KS, Lip GY, Stonelake S and Blann AD: Increased pre-surgical numer of endothelial progenitor cells and circulating endothelial cells in coorectal cancer fail to predict outcome. Int J Colorectal Dis. 30:315–321. 2015. View Article : Google Scholar : PubMed/NCBI
24	Lin CC, Liu CY, Chen MJ, Wang TE, Chu CH, Wang HY, Shih SC, Hsu ML, Hsu TC and Chen YJ: Profiles of circulating endothelial cells and serum cytokines during adjuvant chemoradiation in rectal cancer patients. Clin Transl Oncol. 15:855–860. 2013. View Article : Google Scholar : PubMed/NCBI
25	Starlinger P, Brugger P, Reiter C, Schauer D, Sommerfeldt S, Tamndl D, Kuerher I, Schoppmann SF, Gnant M and Brostjan C: Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy. Neoplasia. 13:980–990. 2011. View Article : Google Scholar : PubMed/NCBI
26	Yu HK, Lee HJ, Choi HN, Ahn JH, Choi JY, Song HS, Lee KH, Yoon Y, Yi LS, Kim JS, et al: Characterization of CD5-/CD31+/CD105+ circulating cells in the peripheral blood of patients with gynecologic malignancies. Clin Cancer Res. 19:5340–5350. 2013. View Article : Google Scholar : PubMed/NCBI
27	Farace F, Gross-Groupil M, Tournay E, Taylor M, Vimond N, Jacques N, Billiot F, Mauguen A, Hill C and Escudier B: Levels of circulating CD45(dim)CD34(+)VEGFR2(+)progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors. Br J Cancer. 104:1144–1150. 2011. View Article : Google Scholar : PubMed/NCBI
28	Bhatt RS, Zurita AJ, O'Neill A, Norden-Zfoni A, Zhan L, Wu HK, Wen PY, George D, Sukhatme VP, Atkins MB and Heymach JV: Increased mobilization of circulating endothelial progenitors in von Hippel-Lindau disease and renal cell carcinoma. Br J Cancer. 105:112–117. 2011. View Article : Google Scholar : PubMed/NCBI
29	Blann AD, Balakrishnan B, Shantsila E, Ryan P and Lip GY: Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: A comparison with plasma vascular markers. Prostate. 71:1047–1053. 2011. View Article : Google Scholar : PubMed/NCBI
30	Fuereder T, Wacheck V, Strommer S, Horak P, Gerschpacher M, Lamm W, Kivaranovic D and Krainer M: Circulating endothelial progenitor cells in castration resistant prostate cancer: A randomized, controlled, biomarker study. PLoS One. 9:e953102014. View Article : Google Scholar : PubMed/NCBI
31	DuBois SG, Stempak D, Wu B, Mokthari RB, Nayar R, Janeway KA, Goldsby R, Grier HE and Baruchel S: Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma. Pediatr Blood Cancer. 58:181–184. 2012. View Article : Google Scholar : PubMed/NCBI
32	Cuppini L, Calleri A, Bruzzone MG, Prodi E, Anghileri E, Pellegatta S, Mancuso P, Porrati P, Di Stefano AL, Cerroni M, et al: Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastoma treated with bevacizumab and irinotecan. PLoS One. 8:e743452013. View Article : Google Scholar : PubMed/NCBI
33	Brunner M, Thurnher D, Heiduscha G, Grasl MCh, Brostjain C and Erovic BM: Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients. J Surg Oncol. 98:545–550. 2008. View Article : Google Scholar : PubMed/NCBI
34	Mancuso P, Antoniotti P, Quarna J, Calleri A, Rabascio C, Tacchetti C, Braidotti P, Wu HK, Zurita AJ, Saronni L, et al: Validation of a standardized method for enumerating circulating endothelial cells and progenitors: Flow cytometry and molecular and ultrastructural analyses. Clin Cancer Res. 15:267–273. 2009. View Article : Google Scholar : PubMed/NCBI
35	Mancuso P, Calleri A, Gregato G, Labanca V, Quarna J, Antoniotti P, Cuppini L, Finocchiaro G, Eoli M, Rosti V and Bertolini F: A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients. PLoS One. 9:e1147132014. View Article : Google Scholar : PubMed/NCBI
36	Wlodkowic D, Telford W, Skommer J and Darzynkiewicz Z: Apoptosis and beyond: Cytometry in studies of programmed cell death. Methods Cell Biol. 103:55–98. 2011. View Article : Google Scholar : PubMed/NCBI
37	Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G and Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:964–967. 1997. View Article : Google Scholar : PubMed/NCBI
38	Pelosi E, Castelli G and Testa U: Endothelial progenitors. Blood Cells Mol Dis. 52:186–194. 2014. View Article : Google Scholar : PubMed/NCBI
39	Fadini GP, Losordo D and Dimmeler S: Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Curr Res. 17:624–637. 2012.
40	Naik RP, Jin D, Chuang E, Gold EG, Tousimis EA, Moore AL, Christos PJ, de Dalmas T, Donovan D, Rafii S and Vahdat LT: Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer. Breast Cancer Res Treat. 107:133–138. 2008. View Article : Google Scholar : PubMed/NCBI
41	Jain S, Ward MM, O'Loughlin J, Boeck M, Wiener N, Chuang E, Cigler T, Moore A, Donovan D, Lam C, et al: Incremental increase in VEGFR2+hematopoietic progenitor cells and VEGFR2+ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients. Breast Cancer Res Treat. 132:235–242. 2012. View Article : Google Scholar : PubMed/NCBI
42	Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, et al: High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer. Clin Cancer Res. 15:1741–1746. 2009. View Article : Google Scholar : PubMed/NCBI
43	Nowak K, Rafat N, Belle S, Weiss C, Hanusch C, Hohenberger P and Beck GCh: Circulating endothelial progenitor cells are increased in human lung cancer and correlate with stage of disease. Eur J Cardiothorac Surg. 37:758–763. 2010. View Article : Google Scholar : PubMed/NCBI
44	Morita R, Sato K, Nakano M, Miura H, Odaka H, Nobori K, Kosaka T, Sano M, Watanabe H, Shioya T and Ito H: Endothelial progenitor cells are associated with response to chemotherapy in human non-small-cell lung cancer. J Cancer Res Clin Oncol. 137:1849–1857. 2011. View Article : Google Scholar : PubMed/NCBI
45	Sakamori Y, Masago K, Ohmori K, Togashi Y, Nagai H, Okuda C, Kim YH, Ichiyama S and Mishima M: Increase in circulating endothelial progenitor cells predicts response in patients with advanced non-small cell lung cancer. Cancer Sci. 103:1065–1070. 2012. View Article : Google Scholar : PubMed/NCBI
46	Pirro M, Cagini L, Paciullo F, Pecoriello R, Mannarino MR, Bagaglia F, Capozzi R, Puma F and Mannarino E: Baseline and post-surgery endothelial progenitor cell levels in patients with early-stage non-small cell lung carcinoma: Impact on cancer recurrences and survival. Eur J Cardiothorac. 44:e245–252. 2013. View Article : Google Scholar
47	Su Y, Zheng L, Wang Q, Li W, Cai Z, Xiong S and Bao J: Quantity and clinical relevance of circulating endothelial progenitor cells in human ovarian cancer. J Exp Clin Cancer Res. 29:272010. View Article : Google Scholar : PubMed/NCBI
48	Qiu H, Cao L, Wang D, Xu H and Laing Z: High levels of circulating CD34+/VEGFR3+ lymphatic/vascular endothelial progenitor cells is correlated with lymph node metastasis in patients with epithelial ovarian cancer. J Obstetr Gynaecol Res. 39:1268–1275. 2013. View Article : Google Scholar
49	Kim YB, Chung YW, Bae HS, Lee JK, Lee NW, Lee KW and Song JY: Circulating endothelial progenitor cells in gynaecological cancer. J Int Med Res. 41:293–299. 2013. View Article : Google Scholar : PubMed/NCBI
50	Yang B, Gu W, Peng B, Xu Y, Liu M, Che J, Geng J and Zheng J: High level of circulating endothelial progenitor cells positively correlates with serum vascular endothelial growth factor in patients with renal cell carcinoma. J Urol. 188:2055–2061. 2012. View Article : Google Scholar : PubMed/NCBI
51	Rafat N, Beck GCh, Schulte J, Tuettenberg J and Vajkoczy P: Circulating endothelial progenitor cells in malignant gliomas. J Neurosurg. 112:43–49. 2010. View Article : Google Scholar : PubMed/NCBI
52	Corsini E, Ciusani E, Gaviani P, Silvani A, Canazza A, Bernardi G, Calatozzolo C, DiMeco F and Salmaggi A: Decrease in circulating endothelial progenitor cells in treated glioma patients. J Neuroncol. 108:123–129. 2012. View Article : Google Scholar
53	Ha X, Zhao M, Zhao H, Peng J, Deng Z, Dong J, Yang X, Zhao Y and Ju J: Identification and clinical significance of circulating endothelial progenitor cells in gastric cancer. Biomarkers. 18:487–492. 2013. View Article : Google Scholar : PubMed/NCBI
54	Sieghart W, Fellner S, Reiberger T, Ulbrich G, Ferlitsch A, Wacheck V and Peck-Radosavljevic M: Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma. Dig Liver Dis. 41:902–906. 2009. View Article : Google Scholar : PubMed/NCBI
55	Van Craenenbroeck EM, Van Craenenbroeck AH, van Ierssel S, Bruydonckx L, Hoymans VY, Vrints CJ and Conraads VM: Quantification of circulating CD3+/KDR+/CD45dim endothelial progenitor cells: Analytical considerations. Int J Cardiol. 167:1688–1695. 2013. View Article : Google Scholar : PubMed/NCBI
56	Verschoor CP, Lelic A, Bramson JL and Bowdish DM: An introduction to automated flow cytometry gating tools and their implementation. Front Immunol. 6:3802015. View Article : Google Scholar : PubMed/NCBI
57	De Palma M and Nucera S: Circulating endothelial progenitors and tumor resistance to vascular-targeting therapies. Cancer Discov. 2:395–397. 2012. View Article : Google Scholar : PubMed/NCBI
58	Bielenberg DR and Zetter BR: The contribution of angiogenesis in the process of metastasis. Cancer J. 21:267–273. 2015. View Article : Google Scholar : PubMed/NCBI
59	Gacche RN: Compensatory angiogenesis and tumor refractoriness. Oncogenesis. 4:e1532015. View Article : Google Scholar : PubMed/NCBI
60	Moccia F, Zuccolo E, Poleto V, Cinelli M, Bonetti E, Guerra G and Rosti V: Endothelial progenitor cells support tumour growth and metastatisation: Implications for the resistance to anti-angiogenic therapy. Tumour Biol. 36:6603–6614. 2015. View Article : Google Scholar : PubMed/NCBI
61	Wilson PM, LaBonte MJ and Lenz HJ: Assessing the in vivo efficacy of biologic antianiogenic therapies. Cancer Chemother Pharmacol. 71:1–12. 2013. View Article : Google Scholar : PubMed/NCBI
62	Yadav L, Puri N, Rastogi V, Satpute P and Sharma V: Tumour angiogenesis and angiogenic inhibitors: A review. J Clin Diagn Res. 9:XE01–XE05. 2015.PubMed/NCBI
63	Hatch AJ, Clarke JM, Nixon AB and Hurwitz HI: Identifying blood-based protein biomarkers for antiangiogenic agents in the clinic. Cancer J. 21:322–326. 2015. View Article : Google Scholar : PubMed/NCBI
64	Mehran R, Nilsson M, Khajavi M, Du Z, Cascone T, Wu HK, Cortes A, Xu L, Zurita A, Schier R, et al: Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy. Cancer Res. 74:2731–2741. 2014. View Article : Google Scholar : PubMed/NCBI
65	Moschetta M, Mishima Y, Sahin I, Manier S, Glavey S, Vacca A, Roccaro AM and Ghobrial IM: Role of endothelial progenitor cells in cancer progression. Biochim Biophys Acta. 1846:26–39. 2014.PubMed/NCBI
66	Marcola M and Rodrigues CE: Endothelia progenitor cells in tumor angiogenesis: Another brick in the wall. Stem Cells Int. 2015:8326492015. View Article : Google Scholar : PubMed/NCBI
67	Ye L and Poh KK: Enhancing endothelial progenitor cell for clinical use. World J Stem Cells. 7:894–898. 2015. View Article : Google Scholar : PubMed/NCBI
68	Cappelletti V, Appierto V, Tiberio P, Fina E, Callari M and Daidone MG: Circulating biomarkers for prediction of treatment response. J Natl Cancer Inst Monogr. 2015:60–63. 2015. View Article : Google Scholar : PubMed/NCBI
69	Pober JS: Just the FACS or stalking the elusive circulating endothelial progenitor cell. Arterioscler Thromb Vasc Biol. 32:837–838. 2012. View Article : Google Scholar : PubMed/NCBI
70	Manzoni M, Comolli G, Torchio M, Mazzini G and Danova M: Circulating endothelial cells and their subpopulations: Role as predictive biomarkers in antiangiogenic therapy for colorectal cancer. Clin Colorectal Cancer. 14:11–17. 2015. View Article : Google Scholar : PubMed/NCBI
71	Ge YZ, Wu R, Lu TZ, Xin H, Yu P, Zhao Y, Liu H, Xu Z, Xu LW, Shen JW, et al: Circulating endothelial progenitor cell: A promising biomarker in clinical oncology. Med Oncol. 32:3322015. View Article : Google Scholar : PubMed/NCBI